EICHOR
● Completed
Delivery Room CPAP in Extremely Low Birth Weight Infants
Condition: Infant, Newborn · Infant, Low Birth Weight · Infant, Small for Gestational Age · Sponsor: NICHD Neonatal Research Network
About this study
This pilot study was designed to determine the feasibility of randomizing extremely low birth weight (ELBW) infants \<28 weeks' gestation who required resuscitation to one of two resuscitation methods, either: (a) 100% oxygen by facemask and continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV) with positive end-expiratory pressure (PEEP), if the infant required PPV (the intervention group); or (b) 100% oxygen and no CPAP and no PEEP if the infant required PPV (the control group).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (6)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| University of California at San Diego | San Diego, California, United States | — |
| University of Miami | Miami, Florida, United States | — |
| RTI International | Durham, North Carolina, United States | — |
| Cincinnati Children's Medical Center | Cincinnati, Ohio, United States | — |
| Case Western Reserve University, Rainbow Babies and Children's Hospital | Cleveland, Ohio, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01223274